Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
30m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
31m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
31m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
31m agoFirst Quantum Minerals Reports First Quarter 2026 Results
31m agoDistrict Metals Announces $10 Million Private Placement Financing
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc

About

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results
Mar 31 2026
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Mar 3 2026
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 24 2026
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
Feb 3 2026
Rigel Appoints Michael P. Miller to the Board of Directors

Financials

Revenue
$294.28 M
Market Cap
$505.42 M
P/E Ratio
1.40
EPS
19.48

Community Chat

Ask AI

6ix6ixAIEvents